BRIEF-Aeglea Bio Therapeutics announces results of preclinical studies of AEB3103
November 21, 2016 at 11:13 AM EST
* Announced results of preclinical studies of AEB3103 showing suppressed growth of tumors in models of prostate, breast cancer